These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9933745)

  • 1. Pathophysiology of peritoneal fluid eosinophilia in peritoneal dialysis patients.
    Ejaz AA; Fitzpatrick PM; Durkin AJ; Wasiluk A; Haley WE; Goalen MJ; Ing TS; Zachariah PK
    Nephron; 1999 Feb; 81(2):125-30. PubMed ID: 9933745
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of chronic peritoneal fluid eosinophilia on peritoneal membrane function.
    Ejaz AA; Zabaneh RI; Ridlon T; Durkin W; Siddiqui T
    J Pak Med Assoc; 1998 Aug; 48(8):233-4. PubMed ID: 10067037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilia in a peritoneal dialysis patient: Questions.
    Tzvi-Behr S; Frishberg Y; Ben-Shalom E; Rinat C; Becker-Cohen R
    Pediatr Nephrol; 2018 Sep; 33(9):1505. PubMed ID: 29147861
    [No Abstract]   [Full Text] [Related]  

  • 4. Eosinophilia in Peritoneal Effluent Due To a Levonorgestrel-Releasing Intrauterine System in a Woman on Peritoneal Dialysis.
    Chen Y; Li Z; Mo L; Feng Z; Li R; Shi W; Liang X
    Perit Dial Int; 2017; 37(3):349-350. PubMed ID: 28512169
    [No Abstract]   [Full Text] [Related]  

  • 5. Peritoneal fluid eosinophilia in patients undergoing maintenance peritoneal dialysis.
    Humayun HM; Ing TS; Daugirdas JT; Gandhi VC; Popli S; Robinson JA; Hano JE; Zayas I
    Arch Intern Med; 1981 Aug; 141(9):1172-3. PubMed ID: 7259377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Output of peritoneal cells during peritoneal dialysis.
    Fakhri O; Al-Mondhiry H; Rifaat UN; Khalil MA; Al-Rawi AM
    J Clin Pathol; 1978 Jul; 31(7):645-7. PubMed ID: 670419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytomorphologic, cytochemical and functional characteristics of cells from the peritoneal dialysate of patients with terminal renal failure treated by intermittent peritoneal dialysis. I. Quantitative and qualitative characteristics of the cells of the peritoneal dialysate].
    Sułowicz W
    Przegl Lek; 1987; 44(3):326-35. PubMed ID: 3615937
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytomorphological, cytochemical and functional characteristics of cells from peritoneal dialysates of patients with terminal renal failure treated by peritoneal dialysis. V. Functional studies--the phagocytic activity].
    Sułowicz W
    Przegl Lek; 1987; 44(11):751-6. PubMed ID: 3447242
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selection of the optimal method of evaluation of peritonitis risk in patients treated by standard peritoneal dialysis].
    Smoszna J; Raczka A; Fuksiewicz A; Wańkowicz Z
    Pol Arch Med Wewn; 1989 Feb; 81(2):92-9. PubMed ID: 2616362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytomorphological, cytochemical and functional characteristics of cells from peritoneal dialysate of patients with terminal renal failure treated by intermittent peritoneal dialysis. VI. Functional studies: evaluation of the effect of isolated macrophages on lymphocytes in culture].
    Sołowicz W
    Przegl Lek; 1987; 44(12):810-6. PubMed ID: 3451304
    [No Abstract]   [Full Text] [Related]  

  • 11. Milky appearance of peritoneal fluid in a neonate on peritoneal dialysis due to end-stage renal disease: Questions.
    Wu X; Vega M; Swartz SJ; Michael M
    Pediatr Nephrol; 2018 Jan; 33(1):71-72. PubMed ID: 28283761
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytomorphological, cytochemical and functional characteristics of cells from peritoneal dialysates of patients with terminal renal failure treated by intermittent peritoneal dialysis. II. Morphological characteristics of the cells from peritoneal fluids].
    Sułowicz W
    Przegl Lek; 1987; 44(7):539-51. PubMed ID: 3685443
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of loss of active heparin in the peritoneal cavity during intermittent peritoneal dialysis].
    Kuźniak J; Grzegorzewska A
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):123-5. PubMed ID: 1437798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of some biochemical indices of renal failure in the abdominal fluid and plasma in patients on peritoneal dialysis].
    Lebek R; Sobczyk J; Twardowski Z
    Pol Arch Med Wewn; 1976 Nov; 56(5):407-10. PubMed ID: 1005167
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of peritoneal dialysis and hemodialysis on respiratory function in patients with chronic renal failure].
    Wanic-Kossowska M
    Pol Arch Med Wewn; 1991 May; 85(5):303-11. PubMed ID: 1896394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritonitis - does peritoneal dialysis modality make a difference?
    Piraino B; Sheth H
    Blood Purif; 2010; 29(2):145-9. PubMed ID: 20093820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of propranolol in peritoneal dialysis fluid by high-performance liquid chromatography without extraction.
    Parrott KA
    J Chromatogr; 1983 May; 274():171-8. PubMed ID: 6874819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid in the Peritoneal Cavity When Measuring Bioimpedance.
    Minguela JI; Aurrekoetxea B; Jimeno I; de Gauna RR
    Perit Dial Int; 2015; 35(5):604-5. PubMed ID: 26450489
    [No Abstract]   [Full Text] [Related]  

  • 19. "Eosinophilic" peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
    Gokal R; Ramos JM; Ward MK; Kerr DN
    Clin Nephrol; 1981 Jun; 15(6):328-30. PubMed ID: 7249431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative biochemical study of serum and residual peritoneal fluid in periodic peritoneal maintenance dialysis (author's transl)].
    Selgas Gutiérrez R; Lorenzo Aguiar D; Rivero Sánchez M; Beberide García JM; Casares Fernández M; Miguel Alonso JL; Sánchez Sicilia L
    Med Clin (Barc); 1981 Sep; 77(5):205-8. PubMed ID: 7329142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.